Skip to main content
Acta Pharmaceutica Sinica. B logoLink to Acta Pharmaceutica Sinica. B
. 2024 Feb 22;14(6):2790. doi: 10.1016/j.apsb.2024.02.014

Author correction to ‘VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity’ [Acta Pharm Sin B 11 (2021) 420–433]

Pengzhao Shang a,, Rui Gao a,, Yijia Zhu a, Xiaorui Zhang a, Yang Wang a, Minji Guo a, Hui Peng b, Min Wang a, Juan Zhang a,
PMCID: PMC11143497  PMID: 38828139

The authors regret that there were some errors or inexact descriptions in the section of acknowledgments.“National Natural Science Foundation of China (Grant 81993223)” should be corrected to “National Natural Science Foundation of China(Grant 81973223)”.

The authors apologize for any inconvenience caused to the journal and readers.

Footnotes

Peer review under the responsibility of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.


Articles from Acta Pharmaceutica Sinica. B are provided here courtesy of Elsevier

RESOURCES